• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝伐单抗可中和血管内皮生长因子对视网膜神经节细胞的保护作用。

Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells.

作者信息

Brar Vikram S, Sharma Rajesh K, Murthy Ravi K, Chalam K V

机构信息

University of Florida College of Medicine, Department of Ophthalmology Jacksonville, FL 32209, USA.

出版信息

Mol Vis. 2010 Sep 12;16:1848-53.

PMID:21031022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2956671/
Abstract

PURPOSE

Vascular endothelial growth factor (VEGF) is well known for its role in pathologic neovascularization, including wet age-related macular degeneration. However, a growing body of evidence indicates that VEGF is also neuroprotective of non-vascular cells in various animal models through reduction of oxidative stress. In light of the widespread use of intraocular anti-VEGF therapies for age-related macular degeneration (AMD), we evaluated the impact of anti-VEGF agents on the neuroprotective effect of VEGF on retinal ganglion cells.

METHODS

Staurosporine differentiated retinal ganglion cells were treated with increasing doses of VEGF in the presence of hydrogen peroxide. After optimization, an increasing concentration of bevacizumab was added to neutralize VEGF-mediated protection. The degree of oxidative damage was measured at various time points using buthionine sulfoxime (BSO), a glutathione reductase inhibitor. Cell viability was assessed using WST-1 and Crystal violet assays.

RESULTS

VEGF (200 ng/ml) protected differentiated retinal ganglion cells (RGC)-5 against H(2)0(2)-mediated oxidative stress. This effect was eliminated by co-treatment with bevacizumab (2.0 mg/ml), which by itself was not cytotoxic.

CONCLUSIONS

These results indicate an important role for VEGF in the maintenance of retinal ganglion cells.

摘要

目的

血管内皮生长因子(VEGF)在病理性新生血管形成中所起的作用已广为人知,包括湿性年龄相关性黄斑变性。然而,越来越多的证据表明,在各种动物模型中,VEGF还可通过减轻氧化应激对非血管细胞起到神经保护作用。鉴于眼内抗VEGF疗法在年龄相关性黄斑变性(AMD)中的广泛应用,我们评估了抗VEGF药物对VEGF对视网膜神经节细胞神经保护作用的影响。

方法

在过氧化氢存在的情况下,用递增剂量的VEGF处理经星形孢菌素分化的视网膜神经节细胞。优化后,添加递增浓度的贝伐单抗以中和VEGF介导的保护作用。使用谷胱甘肽还原酶抑制剂丁硫氨酸亚砜胺(BSO)在不同时间点测量氧化损伤程度。使用WST-1和结晶紫测定法评估细胞活力。

结果

VEGF(200 ng/ml)保护分化的视网膜神经节细胞(RGC)-5免受H₂O₂介导的氧化应激。与贝伐单抗(2.0 mg/ml)共同处理可消除这种作用,而贝伐单抗本身无细胞毒性。

结论

这些结果表明VEGF在维持视网膜神经节细胞方面具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e635/2956671/e2cdd6647872/mv-v16-1848-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e635/2956671/240f87d58da7/mv-v16-1848-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e635/2956671/51c3e70bfbef/mv-v16-1848-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e635/2956671/b3caeb402b59/mv-v16-1848-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e635/2956671/e2cdd6647872/mv-v16-1848-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e635/2956671/240f87d58da7/mv-v16-1848-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e635/2956671/51c3e70bfbef/mv-v16-1848-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e635/2956671/b3caeb402b59/mv-v16-1848-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e635/2956671/e2cdd6647872/mv-v16-1848-f4.jpg

相似文献

1
Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells.贝伐单抗可中和血管内皮生长因子对视网膜神经节细胞的保护作用。
Mol Vis. 2010 Sep 12;16:1848-53.
2
Effect of Anti-vascular Endothelial Growth Factor Antibody on the Survival of Cultured Retinal Ganglion Cells.抗血管内皮生长因子抗体对培养的视网膜神经节细胞存活的影响。
Korean J Ophthalmol. 2017 Aug;31(4):360-365. doi: 10.3341/kjo.2017.0054. Epub 2017 Jul 11.
3
Effect of anti-VEGF antibody on retinal ganglion cells in rats.抗血管内皮生长因子抗体对大鼠视网膜神经节细胞的作用。
Br J Ophthalmol. 2007 Sep;91(9):1230-3. doi: 10.1136/bjo.2007.117309. Epub 2007 May 2.
4
Evaluation of differential toxicity of varying doses of bevacizumab on retinal ganglion cells, retinal pigment epithelial cells, and vascular endothelial growth factor-enriched choroidal endothelial cells.评估不同剂量贝伐单抗对视网膜神经节细胞、视网膜色素上皮细胞和富含血管内皮生长因子的脉络膜内皮细胞的差异毒性。
J Ocul Pharmacol Ther. 2009 Dec;25(6):507-11. doi: 10.1089/jop.2009.0028.
5
Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage.在有或没有先前视网膜神经节细胞损伤的大鼠中进行 VEGF 抑制剂贝伐单抗、雷珠单抗和聚乙二醇化阿柏西普的毒性测试。
Acta Ophthalmol. 2010 Aug;88(5):e170-6. doi: 10.1111/j.1755-3768.2010.01927.x. Epub 2010 May 14.
6
Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.贝伐单抗对不同眼部细胞的抗增殖和细胞毒性特性。
Br J Ophthalmol. 2006 Oct;90(10):1316-21. doi: 10.1136/bjo.2006.095190. Epub 2006 May 24.
7
Effects of Hypoxic Preconditioning and Vascular Endothelial Growth Factor on the Survival of Isolated Primary Retinal Ganglion Cells.缺氧预处理和血管内皮生长因子对分离的原发性视网膜神经节细胞存活的影响。
Biomolecules. 2021 Mar 6;11(3):391. doi: 10.3390/biom11030391.
8
VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons.VEGF 是一种对受损视网膜神经节细胞具有自分泌/旁分泌神经保护作用的因子。
Sci Rep. 2020 Jul 24;10(1):12409. doi: 10.1038/s41598-020-68488-z.
9
The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury.贝伐单抗治疗对视网膜缺血灌注损伤大鼠模型的影响。
Mol Vis. 2018 Mar 23;24:239-250. eCollection 2018.
10
In vitro evaluation of bevacizumab toxicity on a retinal ganglion cell line.贝伐单抗对视网膜神经节细胞系毒性的体外评估。
Acta Ophthalmol. 2009 Sep;87(6):618-22. doi: 10.1111/j.1755-3768.2008.01410.x. Epub 2009 Jun 26.

引用本文的文献

1
Comparative analysis of bevacizumab and sorafenib on the survival of retinal ganglion cells in the treatment of retinal diseases.贝伐单抗与索拉非尼治疗视网膜疾病对视网膜神经节细胞存活影响的比较分析
Sci Rep. 2025 Aug 5;15(1):28587. doi: 10.1038/s41598-025-12199-w.
2
Induction of a Müller Glial Cell-Specific Protective Pathway Safeguards the Retina From Diabetes-Induced Damage.诱导 Müller 胶质细胞特异性保护途径可保护视网膜免受糖尿病诱导的损伤。
Diabetes. 2025 Jan 1;74(1):96-107. doi: 10.2337/db24-0199.
3
Clinical outcomes of treated macular neovascularisation secondary to inherited retinal diseases: a literature review.

本文引用的文献

1
Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors.内源性血管内皮生长因子对视觉功能至关重要:对米勒细胞和光感受器具有存活作用的证据。
PLoS One. 2008;3(11):e3554. doi: 10.1371/journal.pone.0003554. Epub 2008 Nov 3.
2
Neural stem/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression.神经干细胞/祖细胞启动细胞网络的形成,这些细胞网络通过生长因子调节的抗氧化剂表达提供神经保护。
Stem Cells. 2008 Jan;26(1):254-65. doi: 10.1634/stemcells.2007-0221. Epub 2007 Oct 25.
3
Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage.
治疗遗传性视网膜疾病所致黄斑新生血管的临床结局:文献综述。
BMJ Open Ophthalmol. 2023 Jul;8(1). doi: 10.1136/bmjophth-2023-001309.
4
Ganglion Cell Layer Thickness Change in Neovascular Age-Related Macular Degeneration Treated With Anti-VEGF Injections.抗VEGF注射治疗新生血管性年龄相关性黄斑变性时神经节细胞层厚度的变化
J Vitreoretin Dis. 2021 Sep 16;6(2):126-131. doi: 10.1177/24741264211040346. eCollection 2022 Mar-Apr.
5
Bevacizumab induces oxidative cytotoxicity and apoptosis via TRPM2 channel activation in retinal pigment epithelial cells: Protective role of glutathione.贝伐单抗通过激活视网膜色素上皮细胞中的 TRPM2 通道诱导氧化细胞毒性和细胞凋亡:谷胱甘肽的保护作用。
Graefes Arch Clin Exp Ophthalmol. 2021 Jun;259(6):1539-1554. doi: 10.1007/s00417-021-05074-7. Epub 2021 Feb 5.
6
A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies.一种安全的胶质细胞源性神经营养因子(GDNF)和GDNF/脑源性神经营养因子(BDNF)控释系统可改善人视网膜色素上皮细胞的迁移及视网膜神经节细胞的存活:在视网膜退行性病变中的潜在应用价值
Pharmaceuticals (Basel). 2021 Jan 11;14(1):50. doi: 10.3390/ph14010050.
7
Comparison of intravitreal anti-vascular endothelial growth factor agents and treatment results in Irvine-Gass syndrome.玻璃体内抗血管内皮生长因子药物的比较及在Irvine-Gass综合征中的治疗结果
Int J Ophthalmol. 2020 Oct 18;13(10):1586-1591. doi: 10.18240/ijo.2020.10.12. eCollection 2020.
8
Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update.基因治疗干预新生血管性眼病:最新进展。
Mol Ther. 2020 Oct 7;28(10):2120-2138. doi: 10.1016/j.ymthe.2020.06.029. Epub 2020 Jun 30.
9
Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.神经保护策略治疗视网膜神经节细胞变性:现状与挑战。
Int J Mol Sci. 2020 Mar 25;21(7):2262. doi: 10.3390/ijms21072262.
10
Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients.年龄相关性黄斑变性患者连续玻璃体内注射抗血管内皮生长因子后神经节细胞内丛状层的变化。
Korean J Ophthalmol. 2020 Feb;34(1):11-18. doi: 10.3341/kjo.2019.0081.
氧化应激是静水压诱导视网膜神经节细胞损伤过程中的早期事件。
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4580-9. doi: 10.1167/iovs.07-0170.
4
VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo.血管内皮生长因子诱导的血红素加氧酶-1在体内赋予细胞对致死性高氧的保护作用。
FASEB J. 2007 May;21(7):1422-32. doi: 10.1096/fj.06-6661com. Epub 2007 Jan 30.
5
Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice.血管内皮生长因子过表达可延缓肌萎缩侧索硬化症小鼠的神经退行性变并延长其生存期。
J Neurosci. 2007 Jan 10;27(2):304-7. doi: 10.1523/JNEUROSCI.4433-06.2007.
6
Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways.人血管内皮生长因子通过激活ERK-1/2和Akt信号通路在体内保护轴突切断的视网膜神经节细胞。
J Neurosci. 2006 Nov 29;26(48):12439-46. doi: 10.1523/JNEUROSCI.0434-06.2006.
7
Targeting VEGF-A to treat cancer and age-related macular degeneration.靶向血管内皮生长因子-A治疗癌症和年龄相关性黄斑变性。
Annu Rev Med. 2007;58:491-504. doi: 10.1146/annurev.med.58.061705.145635.
8
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.雷珠单抗与维替泊芬治疗新生血管性年龄相关性黄斑变性的比较。
N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655.
9
VEGF expression and receptor activation in the choroid during development and in the adult.发育过程中和成年期脉络膜中的血管内皮生长因子(VEGF)表达及受体激活
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3135-42. doi: 10.1167/iovs.05-1229.
10
The role of oxidative stress in glaucoma.氧化应激在青光眼发病机制中的作用。
Mutat Res. 2006 Mar;612(2):105-14. doi: 10.1016/j.mrrev.2005.11.001. Epub 2006 Jan 18.